应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PCSA Processa Pharmaceuticals, Inc.
已收盘 07-11 16:00:00 EDT
0.2262
-0.0037
-1.61%
盘后
0.2262
+0.0000
0.00%
19:59 EDT
最高
0.2480
最低
0.2177
成交量
565.39万
今开
0.2199
昨收
0.2299
日振幅
13.18%
总市值
592.52万
流通市值
578.04万
总股本
2,619万
成交额
128.24万
换手率
22.13%
流通股本
2,555万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Processa Pharmaceuticals, Inc.7月8日成交额为219.95万美元
市场透视 · 07-09 04:50
Processa Pharmaceuticals, Inc.7月8日成交额为219.95万美元
Processa Pharmaceuticals, Inc.7月7日成交额为81.79万美元
市场透视 · 07-08
Processa Pharmaceuticals, Inc.7月7日成交额为81.79万美元
Processa Pharmaceuticals, Inc.7月2日成交额为84.25万美元
市场透视 · 07-03
Processa Pharmaceuticals, Inc.7月2日成交额为84.25万美元
Processa Pharmaceuticals, Inc.7月1日成交额为138.50万美元
市场透视 · 07-02
Processa Pharmaceuticals, Inc.7月1日成交额为138.50万美元
Processa Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.30%报0.207美元
市场透视 · 06-30
Processa Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.30%报0.207美元
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.42%报0.225美元
市场透视 · 06-27
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.42%报0.225美元
Processa Pharmaceuticals, Inc.股价重挫18.03% 市值跌56.22万美元
市场透视 · 06-23
Processa Pharmaceuticals, Inc.股价重挫18.03% 市值跌56.22万美元
Processa Pharmaceuticals, Inc.股价飙升24.30% 市值涨86.87万美元
市场透视 · 06-20
Processa Pharmaceuticals, Inc.股价飙升24.30% 市值涨86.87万美元
Processa Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.04%
市场透视 · 06-18
Processa Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.04%
Processa Pharmaceuticals, Inc.盘中异动 股价大涨148.78%
市场透视 · 06-17
Processa Pharmaceuticals, Inc.盘中异动 股价大涨148.78%
Processa Pharmaceuticals, Inc.股价重挫17.29% 市值跌43.93万美元
市场透视 · 06-16
Processa Pharmaceuticals, Inc.股价重挫17.29% 市值跌43.93万美元
Processa Pharmaceuticals, Inc.盘中异动 股价大跌16.56%报0.287美元
市场透视 · 06-13
Processa Pharmaceuticals, Inc.盘中异动 股价大跌16.56%报0.287美元
Processa Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.00%报0.380美元
市场透视 · 06-12
Processa Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.00%报0.380美元
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.45%
市场透视 · 06-09
Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.45%
Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.30%
市场透视 · 06-05
Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.30%
Processa Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.37%
市场透视 · 06-03
Processa Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.37%
Processa Pharmaceuticals, Inc.盘中异动 急速上涨5.78%报0.309美元
市场透视 · 06-02
Processa Pharmaceuticals, Inc.盘中异动 急速上涨5.78%报0.309美元
Processa Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.54%报0.320美元
市场透视 · 05-30
Processa Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.54%报0.320美元
Processa Pharmaceuticals, Inc.盘中异动 股价大涨5.30%报0.252美元
市场透视 · 05-27
Processa Pharmaceuticals, Inc.盘中异动 股价大涨5.30%报0.252美元
Processa Pharmaceuticals, Inc.盘中异动 快速拉升7.07%报0.261美元
市场透视 · 05-23
Processa Pharmaceuticals, Inc.盘中异动 快速拉升7.07%报0.261美元
加载更多
公司概况
公司名称:
Processa Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司,致力于药物产品的开发,该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。
发行价格:
--
{"stockData":{"symbol":"PCSA","market":"US","secType":"STK","nameCN":"Processa Pharmaceuticals, Inc.","latestPrice":0.2262,"timestamp":1752264000000,"preClose":0.2299,"halted":0,"volume":5653904,"hourTrading":{"tag":"盘后","latestPrice":0.2262,"preClose":0.2262,"latestTime":"19:59 EDT","volume":314503,"amount":72435.516925,"timestamp":1752278358431},"delay":0,"floatShares":25554300,"shares":26194356,"eps":-3.872706,"marketStatus":"已收盘","change":-0.0037,"latestTime":"07-11 16:00:00 EDT","open":0.2199,"high":0.248,"low":0.2177,"amount":1282383.84684848,"amplitude":0.131796,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.872706,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2299,"preHourTrading":{"tag":"盘前","latestPrice":0.219,"preClose":0.2299,"latestTime":"09:29 EDT","volume":303256,"amount":66839.07802880001,"timestamp":1752240582105},"postHourTrading":{"tag":"盘后","latestPrice":0.2262,"preClose":0.2262,"latestTime":"19:59 EDT","volume":314503,"amount":72435.516925,"timestamp":1752278358431},"volumeRatio":0.306484},"requestUrl":"/m/hq/s/PCSA","defaultTab":"news","newsList":[{"id":"2550137504","title":"Processa Pharmaceuticals, Inc.7月8日成交额为219.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550137504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550137504?lang=zh_cn&edition=full","pubTime":"2025-07-09 12:50","pubTimestamp":1752036643,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日,Processa Pharmaceuticals, Inc.成交额为219.95万美元,成交额较昨日增加168.90%,当日成交量为1049.07万股。Processa Pharmaceuticals, Inc.于2025年7月8日涨9.6%,报0.212美元,该股过去5个交易日涨3.61%,年初至今跌75.97%,过去60日跌19.85%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-08|219.95万|168.90%|1049.07万|#|2025-07-07|81.79万|48.69%|432.19万|#|2025-07-03|55.01万|-34.70%|284.99万|#|2025-07-02|84.25万|-39.17%|438.76万|#|2025-07-01|138.50万|30.82%|702.17万|Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709125050a43f7a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709125050a43f7a38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2549591655","title":"Processa Pharmaceuticals, Inc.7月7日成交额为81.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549591655","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549591655?lang=zh_cn&edition=full","pubTime":"2025-07-08 12:44","pubTimestamp":1751949849,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日,Processa Pharmaceuticals, Inc.成交额为81.79万美元,成交额较昨日增加48.69%,当日成交量为432.19万股。Processa Pharmaceuticals, Inc.于2025年7月7日跌0.51%,报0.194美元,该股过去5个交易日跌1.12%,年初至今跌78.08%,过去60日跌18.91%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-07|81.79万|48.69%|432.19万|#|2025-07-03|55.01万|-34.70%|284.99万|#|2025-07-02|84.25万|-39.17%|438.76万|#|2025-07-01|138.50万|30.82%|702.17万|#|2025-06-30|105.88万|-46.72%|510.08万|Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708124413a69c5387&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708124413a69c5387&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2548581821","title":"Processa Pharmaceuticals, Inc.7月2日成交额为84.25万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548581821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548581821?lang=zh_cn&edition=full","pubTime":"2025-07-03 12:54","pubTimestamp":1751518457,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Processa Pharmaceuticals, Inc.成交额为84.25万美元,成交额较昨日减少39.17%,当日成交量为438.76万股。Processa Pharmaceuticals, Inc.于2025年7月2日跌5.75%,报0.189美元,该股过去5个交易日跌28.33%,年初至今跌78.68%,过去60日跌44.56%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-02|84.25万|-39.17%|438.76万|#|2025-07-01|138.50万|30.82%|702.17万|#|2025-06-30|105.88万|-46.72%|510.08万|#|2025-06-27|198.71万|3.84%|913.29万|#|2025-06-26|191.37万|-21.63%|783.04万|Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703125418a72be946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703125418a72be946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2548859019","title":"Processa Pharmaceuticals, Inc.7月1日成交额为138.50万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548859019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548859019?lang=zh_cn&edition=full","pubTime":"2025-07-02 12:42","pubTimestamp":1751431325,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日,Processa Pharmaceuticals, Inc.成交额为138.50万美元,成交额较昨日增加30.82%,当日成交量为702.17万股。Processa Pharmaceuticals, Inc.于2025年7月1日跌2.44%,报0.2美元,该股过去5个交易日跌30.8%,年初至今跌77.38%,过去60日跌36.1%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-01|138.50万|30.82%|702.17万|#|2025-06-30|105.88万|-46.72%|510.08万|#|2025-06-27|198.71万|3.84%|913.29万|#|2025-06-26|191.37万|-21.63%|783.04万|#|2025-06-25|244.18万|-31.39%|906.38万|Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702124209a729c20e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702124209a729c20e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2547097259","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.30%报0.207美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547097259?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:31","pubTimestamp":1751290289,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时31分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.30%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。其相关个股中,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃,换手率分别为2036.25%、111.29%、58.54%,振幅较大的相关个股有Artelo Biosciences, Inc.、Exicure, Inc.、Relmada Therapeutics, Inc.,振幅分别为27.63%、6.96%、6.56%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213129a4c6c43d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213129a4c6c43d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2546475677","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.42%报0.225美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546475677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546475677?lang=zh_cn&edition=full","pubTime":"2025-06-27 22:34","pubTimestamp":1751034876,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时34分,Processa Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.42%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。其相关个股中,Inmune Bio Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、天境生物涨幅较大,Inmune Bio Inc.、Adial Pharmaceuticals, Inc、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为113.98%、51.22%、28.65%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation、Inmune Bio Inc.,振幅分别为74.75%、62.62%、43.63%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627223436952e3b27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627223436952e3b27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2545417801","title":"Processa Pharmaceuticals, Inc.股价重挫18.03% 市值跌56.22万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417801?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:32","pubTimestamp":1750685546,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时32分,Processa Pharmaceuticals, Inc.股票出现波动,股价快速下挫18.03%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大,Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃,换手率分别为894.81%、893.45%、198.91%,振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.,振幅分别为30.38%、16.07%、14.61%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213226a718f131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213226a718f131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2544400178","title":"Processa Pharmaceuticals, Inc.股价飙升24.30% 市值涨86.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544400178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544400178?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:31","pubTimestamp":1750426297,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时31分,Processa Pharmaceuticals, Inc.股票出现波动,股价急速拉升24.30%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Dermata Therapeutics Inc C/Wts 、Processa Pharmaceuticals, Inc.涨幅较大,Processa Pharmaceuticals, Inc.、Nucana Plc、Aptevo Therapeutics Inc.较为活跃,换手率分别为521.14%、145.96%、122.13%,振幅较大的相关个股有Actuate Therapeutics, Inc.、Xenon制药、Arvinas, Inc.,振幅分别为108.54%、101.91%、101.47%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213137a714a502&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213137a714a502&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2544908363","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544908363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544908363?lang=zh_cn&edition=full","pubTime":"2025-06-18 21:33","pubTimestamp":1750253583,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日21时33分,Processa Pharmaceuticals, Inc.股票出现异动,股价急速下跌6.04%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Geovax Labs, Inc.涨幅较大,Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃,换手率分别为2603.79%、648.70%、120.37%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Biomx Inc.,振幅分别为39.36%、20.59%、17.92%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213303a7109654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618213303a7109654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2544499879","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨148.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544499879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544499879?lang=zh_cn&edition=full","pubTime":"2025-06-17 21:32","pubTimestamp":1750167168,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日21时32分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速拉升148.78%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Acurx Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大,Cero Therapeutics Holdings, Inc.、Salarius Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.较为活跃,换手率分别为1822.85%、1475.87%、855.15%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Processa Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.,振幅分别为44.08%、39.67%、30.40%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617213248a4ae7157&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617213248a4ae7157&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2543603396","title":"Processa Pharmaceuticals, Inc.股价重挫17.29% 市值跌43.93万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543603396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543603396?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:31","pubTimestamp":1750080716,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时31分,Processa Pharmaceuticals, Inc.股票出现波动,股价急速下跌17.29%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Sage Therapeutics, Inc.、Nucana Plc涨幅较大,Nucana Plc、Processa Pharmaceuticals, Inc.、Pmgc Holdings Inc.较为活跃,换手率分别为1107.09%、182.39%、35.71%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Vaxart, Inc. - Common Stock、Equillium, Inc.,振幅分别为12.56%、8.63%、8.13%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213156a70c340a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213156a70c340a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2543800586","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌16.56%报0.287美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543800586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543800586?lang=zh_cn&edition=full","pubTime":"2025-06-13 21:33","pubTimestamp":1749821587,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日21时33分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速下挫16.56%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Cingulate Inc C/Wts 10/12/2026 、乌龙制药涨幅较大,Nucana Plc、Alzamend Neuro, Inc.、Polyrizon Ltd.较为活跃,换手率分别为270.17%、44.23%、10.02%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Bioatla, Inc.,振幅分别为15.97%、15.23%、11.67%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613213307a4a785d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613213307a4a785d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2542510760","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.00%报0.380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542510760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542510760?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:32","pubTimestamp":1749735152,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时32分,Processa Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.00%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Curevac N.V.、Klotho Neurosciences, Inc.涨幅较大,Nucana Plc、Klotho Neurosciences, Inc.、Polyrizon Ltd.较为活跃,换手率分别为953.39%、70.04%、46.26%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tnf Pharmaceuticals, Inc.、Immunoprecise Antibodies Ltd.,振幅分别为28.10%、18.69%、14.99%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061221323295198ac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061221323295198ac5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2542333330","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542333330?lang=zh_cn&edition=full","pubTime":"2025-06-09 22:04","pubTimestamp":1749477851,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日22时04分,Processa Pharmaceuticals, Inc.股票出现波动,股价急速上涨6.45%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Synaptogenix, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大,Pmgc Holdings Inc.、Synaptogenix, Inc.、Nucana Plc较为活跃,换手率分别为1547.19%、933.17%、710.83%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为149.22%、51.70%、43.48%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092204119514dcc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092204119514dcc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2541008978","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541008978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541008978?lang=zh_cn&edition=full","pubTime":"2025-06-06 02:32","pubTimestamp":1749148374,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日02时32分,Processa Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.30%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Liminatus Pharma Inc C/Wts 30/04/2030 、Immatics N V C/Wts 01/07/2025 、Liminatus Pharma, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Nucana Plc、Eyenovia, Inc.较为活跃,换手率分别为1976.00%、823.35%、286.61%,振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Scinai Immunotherapeutics Ltd、Liminatus Pharma, Inc.,振幅分别为145.64%、142.06%、75.39%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606023254977350c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606023254977350c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2540778707","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540778707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540778707?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:45","pubTimestamp":1748958355,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日21时45分,Processa Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.37%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Traws Pharma, Inc.、Renovaro Inc.、Oragenics Inc.涨幅较大,Revelation Biosciences, Inc.、Traws Pharma, Inc.、Nucana Plc较为活跃,换手率分别为3562.88%、878.19%、699.07%,振幅较大的相关个股有Oragenics Inc.、Renovaro Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为51.50%、37.39%、35.82%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603214555950d05b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603214555950d05b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2540968997","title":"Processa Pharmaceuticals, Inc.盘中异动 急速上涨5.78%报0.309美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540968997","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540968997?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:33","pubTimestamp":1748871211,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时33分,Processa Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.78%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Lyra Therapeutics, Inc.、Oragenics Inc.、Vera Therapeutics, Inc.涨幅较大,Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为984.13%、593.65%、262.20%,振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Nutriband Inc C/Wts ,振幅分别为72.82%、57.67%、41.96%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213332a6f72417&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213332a6f72417&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2539278536","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.54%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539278536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539278536?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:34","pubTimestamp":1748612087,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时34分,Processa Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.54%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为3.70%。其相关个股中,Bioline Rx Ltd、Psyence Biomedical Ltd C/Wts 25/01/2029、Imunon, Inc.涨幅较大,Bioline Rx Ltd、Nucana Plc、Psyence Biomedical Ltd.较为活跃,换手率分别为322.29%、139.39%、79.25%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Imunon, Inc.、Bioline Rx Ltd,振幅分别为49.50%、26.63%、22.42%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213448976b3597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213448976b3597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2538546404","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨5.30%报0.252美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538546404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538546404?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:48","pubTimestamp":1748353737,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时48分,Processa Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.30%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Forte Biosciences, Inc.、Gyre Therapeutics, Inc.涨幅较大,Nucana Plc、Bioxcel Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为261.72%、76.99%、71.13%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为60.00%、39.22%、33.52%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052721485797674258&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052721485797674258&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2537156721","title":"Processa Pharmaceuticals, Inc.盘中异动 快速拉升7.07%报0.261美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537156721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537156721?lang=zh_cn&edition=full","pubTime":"2025-05-24 01:38","pubTimestamp":1748021892,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日01时38分,Processa Pharmaceuticals, Inc.股票出现波动,股价大幅拉升7.07%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.48%。其相关个股中,Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃,换手率分别为4294.56%、2285.03%、1092.31%,振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.,振幅分别为208.33%、170.40%、101.08%。Processa Pharmaceuticals, Inc.公司简介:Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524013812aa2c989e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524013812aa2c989e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.processapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.1802},{"period":"1month","weight":-0.3307},{"period":"3month","weight":-0.076},{"period":"6month","weight":-0.7299},{"period":"1year","weight":-0.8656},{"period":"ytd","weight":-0.7399}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司,致力于药物产品的开发,该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.248045},{"month":2,"riseRate":0.571429,"avgChangeRate":0.073235},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.127227},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.105856},{"month":5,"riseRate":0.375,"avgChangeRate":-0.066944},{"month":6,"riseRate":0.625,"avgChangeRate":0.111789},{"month":7,"riseRate":0.25,"avgChangeRate":-0.08033},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.10415},{"month":9,"riseRate":0.571429,"avgChangeRate":0.100987},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.118178},{"month":11,"riseRate":0.428571,"avgChangeRate":0.093414},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.169338}],"exchange":"NASDAQ","name":"Processa Pharmaceuticals, Inc.","nameEN":"Processa Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Processa Pharmaceuticals, Inc.,PCSA,Processa Pharmaceuticals, Inc.股票,Processa Pharmaceuticals, Inc.股票老虎,Processa Pharmaceuticals, Inc.股票老虎国际,Processa Pharmaceuticals, Inc.行情,Processa Pharmaceuticals, Inc.股票行情,Processa Pharmaceuticals, Inc.股价,Processa Pharmaceuticals, Inc.股市,Processa Pharmaceuticals, Inc.股票价格,Processa Pharmaceuticals, Inc.股票交易,Processa Pharmaceuticals, Inc.股票购买,Processa Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}